Article by: Janet Jackim In this article, we report not only on the expected implications from cannabis’ rescheduling but also on numerous surprises to the cannabis industry as a result of the expected reclassification of cannabis as a Schedule III drug, which was announced to the public on April 30, 2024 and the proposed rescheduling…
Article by: Tom Zuber, Janet Jackim, and Jim Ickes The Drug Enforcement Administration (DEA) has recently clarified its stance, indicating that THC-A, a precursor to the psychoactive compound THC, does not qualify as legal hemp under current federal law. This statement comes at a pivotal moment as legislative bodies consider amendments to the upcoming Farm…
We are delighted to share that Zuber Lawler’s appellate practice has been ranked #1 in the 2024 edition of RANKING ARIZONA® The Best of Arizona Business. This recognition from the Arizona business community means the world to us. Special thanks to Robert A. Mandel, who leads our firm’s Appellate Practice Team. To our peers, clients,…